login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SIGHT SCIENCES INC (SGHT) Stock News
USA
- NASDAQ:SGHT -
US82657M1053
-
Common Stock
4.98
USD
-0.12 (-2.35%)
Last: 11/4/2025, 8:00:02 PM
4.98
USD
0 (0%)
After Hours:
11/4/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SGHT Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
- Mentions:
ACHV
LBRT
EQ
RCEL
...
Top movers in Friday's session
19 days ago - By: Chartmill
- Mentions:
PLX
ACHV
LBRT
STRO
...
Top stock movements in today's session.
16 hours ago - By: Sight Sciences, Inc.
Sight Sciences to Present at Two Upcoming Investor Conferences
13 days ago - By: Sight Sciences, Inc.
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
19 days ago - By: Benzinga
- Mentions:
XRTX
ACHV
GNPX
KZR
...
12 Health Care Stocks Moving In Friday's Intraday Session
19 days ago - By: Chartmill
- Mentions:
PLX
SLI
KEP
MB
...
Which stocks are gapping on Friday?
19 days ago - By: Sight Sciences, Inc.
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure
2 months ago - By: Sight Sciences, Inc.
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use
2 months ago - By: Sight Sciences, Inc.
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments
2 months ago - By: Sight Sciences, Inc.
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
2 months ago - By: Zacks Investment Research
- Mentions:
JNJ
ALC
GKOS
Glaukos Builds Dual Growth Engines Amid Market Headwinds
2 months ago - By: Sight Sciences, Inc.
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
3 months ago - By: Benzinga
What 4 Analyst Ratings Have To Say About Sight Sciences
3 months ago - By: Zacks Investment Research
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics
3 months ago - By: Zacks Investment Research
- Mentions:
DRIO
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
VCYT
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates
3 months ago - By: Sight Sciences, Inc.
Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease
3 months ago - By: Sight Sciences, Inc.
Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease
3 months ago - By: Sight Sciences, Inc.
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
6 months ago - By: Zacks Investment Research
Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
CLPT
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Sight Sciences, Inc.
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
6 months ago - By: Sight Sciences, Inc.
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
6 months ago - By: Zacks Investment Research
- Mentions:
AORT
Artivion (AORT) Lags Q1 Earnings Estimates
6 months ago - By: Sight Sciences, Inc.
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
7 months ago - By: Sight Sciences, Inc.
Sight Sciences Appoints Gary Burbach to its Board of Directors
7 months ago - By: Sight Sciences, Inc.
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
7 months ago - By: Sight Sciences, Inc.
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
8 months ago - By: Sight Sciences, Inc.
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
8 months ago - By: Sight Sciences, Inc.
Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting
9 months ago - By: Sight Sciences, Inc.
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
Please enable JavaScript to continue using this application.